ProfileGDS4459 / ENSG00000016864
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 96% 96% 93% 95% 95% 95% 93% 95% 92% 93% 95% 94% 93% 95% 95% 96% 95% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 18.6196
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 28.2796
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.9193
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 48.0495
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.2595
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 68.2295
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.7593
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.1895
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.7392
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.7993
GSM623474group B, liver allograft wedge biopsie placebo treatment 18.4895
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.1394
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.7593
GSM623477group B, liver allograft wedge biopsie placebo treatment 48.2295
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.3395
GSM623479group B, liver allograft wedge biopsie placebo treatment 68.5796
GSM623480group B, liver allograft wedge biopsie placebo treatment 78.2595